These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 22941287)

  • 1. New insights into huperzine A for the treatment of Alzheimer's disease.
    Zhang HY
    Acta Pharmacol Sin; 2012 Sep; 33(9):1170-5. PubMed ID: 22941287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on huperzine A as a treatment for Alzheimer's disease.
    Little JT; Walsh S; Aisen PS
    Expert Opin Investig Drugs; 2008 Feb; 17(2):209-15. PubMed ID: 18230054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-cholinergic effects of huperzine A: beyond inhibition of acetylcholinesterase.
    Zhang HY; Yan H; Tang XC
    Cell Mol Neurobiol; 2008 Feb; 28(2):173-83. PubMed ID: 17657601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing iron in the brain: a novel pharmacologic mechanism of huperzine A in the treatment of Alzheimer's disease.
    Huang XT; Qian ZM; He X; Gong Q; Wu KC; Jiang LR; Lu LN; Zhu ZJ; Zhang HY; Yung WH; Ke Y
    Neurobiol Aging; 2014 May; 35(5):1045-54. PubMed ID: 24332448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer's Disease.
    Friedli MJ; Inestrosa NC
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer's disease.
    Wang R; Tang XC
    Neurosignals; 2005; 14(1-2):71-82. PubMed ID: 15956816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Huperzine a as potential treatment of Alzheimer's disease: an assessment on chemistry, pharmacology, and clinical studies.
    Ha GT; Wong RK; Zhang Y
    Chem Biodivers; 2011 Jul; 8(7):1189-204. PubMed ID: 21766442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Huperzine A, a potential therapeutic agent for treatment of Alzheimer's disease.
    Bai DL; Tang XC; He XC
    Curr Med Chem; 2000 Mar; 7(3):355-74. PubMed ID: 10637369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased accumulation of subcellular amyloid-β with improved mitochondrial function mediates the neuroprotective effect of huperzine A.
    Yang L; Ye CY; Huang XT; Tang XC; Zhang HY
    J Alzheimers Dis; 2012; 31(1):131-42. PubMed ID: 22531425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Huperzine a: an acetylcholinesterase inhibitor with high pharmacological potential].
    Pilotaz F; Masson P
    Ann Pharm Fr; 1999 Sep; 57(5):363-73. PubMed ID: 10520506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Huperzine A--an interesting anticholinesterase compound from the Chinese herbal medicine.
    Patocka J
    Acta Medica (Hradec Kralove); 1998; 41(4):155-7. PubMed ID: 9951045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Lycopodium alkaloids.
    Ma X; Gang DR
    Nat Prod Rep; 2004 Dec; 21(6):752-72. PubMed ID: 15565253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbial acetylcholinesterase inhibitors for Alzheimer's therapy: recent trends on extraction, detection, irradiation-assisted production improvement and nano-structured drug delivery.
    Zaki AG; El-Sayed ER; Abd Elkodous M; El-Sayyad GS
    Appl Microbiol Biotechnol; 2020 Jun; 104(11):4717-4735. PubMed ID: 32285176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Huperzia quadrifariata and Huperzia reflexa alkaloids inhibit acetylcholinesterase activity in vivo in mice brain.
    Konrath EL; Neves BM; Passos Cdos S; Lunardi PS; Ortega MG; Cabrera JL; Gonçalves CA; Henriques AT
    Phytomedicine; 2012 Nov; 19(14):1321-4. PubMed ID: 23022390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Huperzine A attenuates amyloid beta-peptide fragment 25-35-induced apoptosis in rat cortical neurons via inhibiting reactive oxygen species formation and caspase-3 activation.
    Xiao XQ; Zhang HY; Tang XC
    J Neurosci Res; 2002 Jan; 67(1):30-6. PubMed ID: 11754078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease-Modifying Activity of Huperzine A on Alzheimer's Disease: Evidence from Preclinical Studies on Rodent Models.
    Yan YP; Chen JY; Lu JH
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease.
    Zangara A
    Pharmacol Biochem Behav; 2003 Jun; 75(3):675-86. PubMed ID: 12895686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three new Lycopodium alkaloids from Lycopodium obscurum.
    Pan K; Luo JG; Kong LY
    J Asian Nat Prod Res; 2013; 15(5):441-5. PubMed ID: 23600717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in studies of huperzine A, a natural cholinesterase inhibitor from Chinese herbal medicine.
    Wang R; Yan H; Tang XC
    Acta Pharmacol Sin; 2006 Jan; 27(1):1-26. PubMed ID: 16364207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of huperzine A: new therapeutic targets for neurodegenerative disease.
    Zhang HY; Tang XC
    Trends Pharmacol Sci; 2006 Dec; 27(12):619-25. PubMed ID: 17056129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.